Uniflu vaccine - VA Pharma Limited Liability Company
Alternative Names: High dose universal influenza vaccine uniflu; Low dose universal influenza vaccine uniflu; Recombinant universal influenza vaccine UnifluLatest Information Update: 28 Sep 2022
At a glance
- Originator VA Pharma Limited Liability Company
- Class Influenza virus vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 28 Sep 2022 No recent reports of development identified for phase-I development in Influenza-virus-infections(Prevention, In adults) in Russia (IM)